课题基金 / 基金详情

项目摘要

项目成果

JONATHAN P KATZ的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY (MOLECULAR PATHOLOGY & IMAGING CORE) The Molecular Pathology and Imaging Core (MPIC) is a unique entity at the University of Pennsylvania and provides tremendous service, resources, expertise, and efficiency for investigators of the Center for Molecular Studies in Digestive and Liver Diseases (CMSDLD). The MPIC has specific expertise in processing and analyses of all tissue types relevant to the CMSDLD and includes specialized microscopes, as well as other reagents and equipment essential for the research of CMSDLD investigators; no resource with similar expertise exists on the Penn campus or in nearby institutions. In addition, by providing cost-effective approaches, the MPIC is particular beneficial to Pilot and Feasibility awardees, who receive subsidies for MPIC services, and junior investigators/Associate Members, many of whom do not yet have independent funding. Established in 1995 as part of a Program Project grant, the MPIC expanded in 1997 to serve CMSDLD investigators and, since its inception, has been heavily utilized and extremely successful, serving as a model core facility for numerous other Centers and Program Projects at the University of Pennsylvania and throughout the country. The MPIC is a key component of the CMSDLD, providing essential, routine services as well as cutting edge technologies to CMSDLD investigators. Currently comprising more than 1,000 square feet on the 9th floor of BRBII/III, the MPIC is lead by an experienced Director and Technical Director and supported by a highly-trained staff. Moreover, working with other Cores and Centers, the MPIC expands the resources and services available to CMSDLD investigators, and since the last competitive renewal of this application, the MPIC has continued to incorporate and integrate new services and technologies. Additionally, the MPIC promotes new and exciting collaborations and research directions. Overall, the MPIC serves the CMSDLD by pursuing the following two interrelated Specific Aims: (1) To enhance the efficiency and productivity of CMSDLD members by providing specialized technical resources, services, and expertise in histology, pathology, and imaging of the digestive tract, liver, and pancreas; and (2) To integrate new technologies that advance research and discovery for studies of digestive, liver, and pancreatic diseases by both surveying and anticipating the needs of CMSDLD members. As such, the MPIC provides exceptional utility, quality, value, experience, service, and commitment to the CMSDLD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cytoprotective pathways in esophageal squamous epithelia
  • 批准号:
    10660394
  • 项目类别:
  • 资助金额:
    $59.66万
  • 财政年份:
    2023
  • 负责人:
    JONATHAN P KATZ
  • 依托单位:
KLF4 and WNT5A in esophageal epithelial differentiation and stratification
  • 批准号:
    9889959
  • 项目类别:
  • 资助金额:
    $36.45万
  • 财政年份:
    2019
  • 负责人:
    JONATHAN P KATZ
  • 依托单位:
KLF4 and WNT5A in esophageal epithelial differentiation and stratification
  • 批准号:
    10374840
  • 项目类别:
  • 资助金额:
    $36.56万
  • 财政年份:
    2019
  • 负责人:
    JONATHAN P KATZ
  • 依托单位:
Regulation of esophageal gene expression and function by KLF5 and p53
  • 批准号:
    8652150
  • 项目类别:
  • 资助金额:
    $34.8万
  • 财政年份:
    2013
  • 负责人:
    JONATHAN P KATZ
  • 依托单位:
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
  • 批准号:
    81903002
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.5万元
  • 批准年份:
    2019
  • 负责人:
    王斐斐
  • 依托单位: